infoJustice

Day October 19, 2015

Challenging the Use of the US Special 301 Procedures against Developing Country Access to Medicines Policies – Indian Pharmaceutical Patents and the WTO

Author: Suzanne Zhou Abstract: In April 2014, the United States Trade Representative (USTR) listed India on its Special 301 Priority Watch List, following India’s refusal to grant a patent over the leukemia drug Gleevec and its compulsory licensing of the…

Papers
October 19, 2015

National IPR Policy Series: Quick Observations on the Leaked Draft of the National IPR Policy

[Originally posted on CIS-India, Link (CC-BY)] Earlier this week, the “Don’t Trade Our Lives Away” blog leaked the supposed final draft of India’s National IPR Policy (“leaked draft”). This article presents quick comments on this leaked draft. The leaked draft…

Nehaa Chaudhari
October 19, 2015

TPP Governments Try to Lessen Stakeholder ISDS Fears

Trans Pacific Partnership governments are trying to convince stakeholders that the controversial Investor-State Dispute Settlement (ISDS) mechanism in the agreement is an improvement over those found in previous trade agreements. ISDS rules in NAFTA have allowed Eli Lilly to sue…

Mike Palmedo
October 19, 2015